Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
February 16th, 2015
•The lymphodepletive and immunomodulatory effects of chemotherapy and radiation standard of care can be leveraged to enhance the antitumor efficacy of T cell immunotherapy. We outline a method for generating EGFRvIII-specific chimeric antigen receptor (CAR) T cells and administering them in the context of glioblastoma standard of care.
Related Videos
Retroviral Transduction of T-cell Receptors in Mouse T-cells
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
piggyBac Transposon System Modification of Primary Human T Cells
Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
Generation of Human Alloantigen-specific T Cells from Peripheral Blood
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved